NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, NEW
ZEALAND, HONG KONG, JAPAN, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR ANY
OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE
UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO
IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE.

Reference is made to the stock exchange announcement made by Inify Laboratories
AB (the "Company") on 9 January 2025 regarding the commencement of the
subscription period in a fully guaranteed subsequent repair offering of
3,464,300 new shares in the Company (the "Subsequent Offer Shares"), at an offer
price of NOK 4.50 per Subsequent Offer Share (the "Offer Price"), with gross
proceeds of NOK 15,589,350 (the "Subsequent Offering").

The subscription period for the Subsequent Offering will expire today, 23
January 2025 at 16:30 hours (CET). Correctly completed subscription forms must
be received by the Manager (as defined below) before the end of the subscription
period. Subscription rights that are not used to subscribe for Subsequent Offer
Shares before the expiry of the subscription period will expire and have no
value.

Please see the national prospectus dated 6 January 2025 prepared by the Company
(the "Prospectus") for more information about the Subsequent Offering, including
subscription procedures and the complete terms of the Subsequent Offering.
Subscriptions may only be made on the basis of the Prospectus. The Prospectus is
available at the following website:
https://www.sb1markets.no/en/transactions/ (https://protect.checkpoint.com/v2/r0
2
/___https://www.sb1markets.no/jsdywfsxfhyntsxd___.YzJlOnNjaGpkdGFzOmM6bzpiMWNmYW
U
1MGZhZTc0ZDlkMTM1Yzk0MTYyMmIwNmUzMzo3OjE4MDE6NDIxMmI1NTQ3MzY3MWVmOGY1ODQzNDg2MTV
i
OTA4MmQwOWI5MmRhNmZmNGFhZjA2YTgyNDRhMjc0ODBkNTQzMjpwOlQ6VA).

Advisors

SpareBank 1 Markets AS (the "Manager") has been appointed as financial advisor
in connection with the Subsequent Offering. Schjødt law firm acts as legal
counsel to the Company.

For further information, please contact CEO, Fredrik Palm,
fredrik.palm@inify.com, or visit https://www.inify.com

###

The future of pathology

Inify Laboratories provides cancer diagnostics through ultramodern laboratory
services within pathology. It uses a fully digital, standardized and AI
-supported workflow to optimize quality and response times, initially within
prostate. The concept is scalable and can be extended to other diagnoses.

The service includes the whole chain of sample handling: from logistics, to
sample preparation, to reporting by a pathologist. The report is assisted by our
own AI, proven in clinical studies to have world-leading accuracy. The complete
workflow is supported by a tailor-made process control system.

The company, based in Sweden, became independent in 2022 through a spin-off from
ContextVision(https://www.contextvision.com/), with 40 years of experience
within digital imaging for medical applications. It is listed on Euronext Growth
Oslo under the ticker INIFY.

This information is subject to the disclosure requirements pursuant to section 5
-12 the Norwegian Securities Trading Act.

Important information

The release, announcement or distribution of this press release may, in certain
jurisdictions, be subject to restrictions. The recipients of this press release
in jurisdictions where this press release has been published or distributed
shall inform themselves of and follow such restrictions. The recipient of this
press release is responsible for using this press release, and the information
contained herein, in accordance with applicable rules in each jurisdiction. The
information in this press release does not contain or constitute an offer to
acquire, subscribe or otherwise trade in shares, subscription rights or other
securities in the Company in any jurisdiction. Any invitation to the persons
concerned to subscribe for shares in the Subsequent Offering will only be made
through the Prospectus.

This press release does not identify or suggest, or purport to identify or
suggest, the risks (direct or indirect) that may be associated with an
investment in new shares. Any investment decision in connection with the
Subsequent Offering must be made on the basis of the information included in the
Prospectus. Such information has not been independently verified by SpareBank 1
Markets. The information contained in this announcement is for background
purposes only and does not purport to be full or complete. No reliance may be
placed for any purpose on the information contained in this announcement or its
accuracy or completeness. SpareBank 1 Markets is acting for the Company in
connection with the transaction and no one else and will not be responsible to
anyone other than the Company for providing the protections afforded to its
clients nor for giving advice in relation to the transaction or any other matter
referred to herein.

This press release does not constitute a recommendation concerning any
investor's option with respect to the Subsequent Offering. Each investor or
prospective investor should conduct his, her or its own investigation, analysis
and evaluation of the business and data described in this announcement and
publicly available information. The price and value of securities can go down as
well as up. Past performance is not a guide to future performance.

The information contained in this press release is not intended for, and must
not be accessed by, or distributed or disseminated, directly or indirectly, in
whole or in part, to persons resident or physically present in the United States
of America (including its territories and possessions, any state of the United
States and the District of Columbia) (the "United States"), Australia, Canada,
Hong Kong, Japan, New Zealand, Singapore, South Africa, United Kingdom or any
other jurisdiction where such action is wholly or partially subject to legal
restrictions, or would require additional prospectuses, registration or other
measures than those required by Norwegian law. The information in the press
release does not constitute any offer regarding subscription rights, paid
subscribed shares or shares in the Company ("Securities") to any person in said
jurisdictions. The information in the press release may not be forwarded or
reproduced in such a manner that contravenes such restrictions or gives cause to
such requirements.

No securities have been or will be registered under the United States Securities
Act of 1933, as amended (the "Securities Act") or the securities legislation of
any state or other jurisdiction in the United States and may not be offered,
subscribed for, exercised, used, pledged, sold, resold, granted, delivered or
otherwise transferred, directly or indirectly, in or into the United States
except pursuant to an applicable exemption from, or in a transaction not subject
to, the registration requirements under the Securities Act and in compliance
with the securities legislation in the relevant state or any other jurisdiction
of the United States.

Within the European Economic Area ("EEA"), no public offering of Securities is
made in other countries than Sweden or Norway. In other member states of the EU,
such an offering of Securities may only be made in accordance with the
Prospectus Regulation (EU) 2017/1129 (the "Prospectus Regulation"). In other
member states of the EEA which have implemented the Prospectus Regulation in its
national legislation, any offer of Securities may only be made in accordance
with an applicable exemption in the Prospectus Regulation and/or in accordance
with an applicable exemption under a relevant national implementation measure.

In the United Kingdom, this document and any other materials in relation to the
securities described herein is only being distributed to, and is only directed
at, and any investment or investment activity to which this document relates is
available only to, and will be engaged in only with, "qualified investors" who
are (i) persons having professional experience in matters relating to
investments who fall within the definition of "investment professionals" in
Article 19(5) of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005 (the "Order")